MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ctr.13371

Медицинская библиотека · Clinical transplantation · 2018

Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.

Gavriilaki Eleni, Sakellari Ioanna, Batsis Ioannis, Mallouri Despina, Bousiou Zoi, Vardi Anna, Yannaki Evangelia, Constantinou Varnavas, Tsompanakou Aliki, Vadikoliou Chrysanthi, Kaloyannidis Panayotis, Bamihas Gerasimos, Anagnostopoulos Achilles

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Renewed interest has emerged in transplant-associated thrombotic microangiopathy (TA-TMA) with novel prognostic, diagnostic, and treatment algorithms. We aimed to investigate the incidence, prognostic factors, morbidity, and mortality of TA-TMA in allogeneic hematopoietic cell transplantation (HCT) recipients. We enrolled consecutive HCT recipients (1990-2017). Among 758 patients, 116 (15.5%) were diagnosed with TA-TMA. In the multivariate analysis, TBI-based conditioning, viral infections, acute and chronic GVHD remained independent predictors of TA-TMA. With a median follow-up of 23 (range 0.1-329) months, TA-TMA resulted in significantly lower overall survival (OS). In the multivariate analysis, TA-TMA remained an independent predictor of OS, along with relapse, acute, and chronic GVHD. Among 116 TA-TMA patients, 70 developed renal (56) and/or neurologic (26) dysfunction that would be necessary for TA-TMA diagnosis according to the Bone Marrow Transplant Clinical Trials Network criteria. TA-TMA patients with renal dysfunction showed increased rates of acute GVHD, but no difference in OS compared to patients without renal dysfunction. However, neurologic dysfunction resulted in significantly lower OS. In conclusion, TA-TMA is associated with increased morbidity and mortality in allogeneic transplant recipients. Successful prevention and treatment strategies of infections and GVHD need to be timely employed to improve survival in this complex setting.

Для цитирования: Gavriilaki Eleni, Sakellari Ioanna, Batsis Ioannis, Mallouri Despina, Bousiou Zoi, Vardi Anna, Yannaki Evangelia, Constantinou Varnavas, Tsompanakou Aliki, Vadikoliou Chrysanthi, Kaloyannidis Panayotis, Bamihas Gerasimos, Anagnostopoulos Achilles. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.. Clinical transplantation. 2018. DOI: 10.1111/ctr.13371.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.